Literature DB >> 19185987

Oxidative stress in prostate cancer.

Lakshmipathi Khandrika1, Binod Kumar, Sweaty Koul, Paul Maroni, Hari K Koul.   

Abstract

As prostate cancer and aberrant changes in reactive oxygen species (ROS) become more common with aging, ROS signaling may play an important role in the development and progression of this malignancy. Increased ROS, otherwise known as oxidative stress, is a result of either increased ROS generation or a loss of antioxidant defense mechanisms. Oxidative stress is associated with several pathological conditions including inflammation and infection. ROS are products of normal cellular metabolism and play vital roles in stimulation of signaling pathways in response to changing intra- and extracellular environmental conditions. Chronic increases in ROS over time are known to induce somatic mutations and neoplastic transformation. In this review we summarize the causes for increased ROS generation and its potential role in etiology and progression of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185987      PMCID: PMC2789743          DOI: 10.1016/j.canlet.2008.12.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  98 in total

Review 1.  Chronic prostatitis-an infectious disease?

Authors:  K G Naber; W Weidner
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Aging: a theory based on free radical and radiation chemistry.

Authors:  D HARMAN
Journal:  J Gerontol       Date:  1956-07

3.  An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells.

Authors:  J Miquel
Journal:  Arch Gerontol Geriatr       Date:  1991 Mar-Jun       Impact factor: 3.250

Review 4.  Altered metabolism and mitochondrial genome in prostate cancer.

Authors:  G D Dakubo; R L Parr; L C Costello; R B Franklin; R E Thayer
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 5.  The biology of hormone refractory prostate cancer. Why does it develop?

Authors:  J T Isaacs
Journal:  Urol Clin North Am       Date:  1999-05       Impact factor: 2.241

6.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

7.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

Review 8.  Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome.

Authors:  Ryszard Olinski; Daniel Gackowski; Marek Foksinski; Rafal Rozalski; Krzysztof Roszkowski; Pawel Jaruga
Journal:  Free Radic Biol Med       Date:  2002-07-15       Impact factor: 7.376

Review 9.  Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.

Authors:  Yu Wang; Jeffrey I Kreisberg; Paramita M Ghosh
Journal:  Curr Cancer Drug Targets       Date:  2007-09       Impact factor: 3.428

10.  Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation.

Authors:  Kyle D Mansfield; Robert D Guzy; Yi Pan; Regina M Young; Timothy P Cash; Paul T Schumacker; M Celeste Simon
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

View more
  156 in total

1.  Combined measure of pro- and anti-oxidant exposures in relation to prostate cancer and colorectal adenoma risk: an update.

Authors:  Michael Goodman; Roberd M Bostick; Myron Gross; Bharat Thyagarajan; Chiranjeev Dash; W Dana Flanders
Journal:  Ann Epidemiol       Date:  2010-12       Impact factor: 3.797

2.  A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Authors:  Melanie J Grubisha; M E Cifuentes; Stephen R Hammes; Donald B Defranco
Journal:  Mol Endocrinol       Date:  2012-05-16

3.  Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.

Authors:  Wen-Chin Huang; Xiangyan Li; Jian Liu; Jentai Lin; Leland W K Chung
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

4.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

5.  DNA damage phenotype and prostate cancer risk.

Authors:  O Kosti; L Goldman; D T Saha; R A Orden; A J Pollock; H L Madej; A W Hsing; L W Chu; J H Lynch; R Goldman
Journal:  Mutat Res       Date:  2010-11-21       Impact factor: 2.433

6.  Quantitation of Lipid Peroxidation Product DNA Adducts in Human Prostate by Tandem Mass Spectrometry: A Method That Mitigates Artifacts.

Authors:  Haoqing Chen; Sesha Krishnamachari; Jingshu Guo; Lihua Yao; Paari Murugan; Christopher J Weight; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2019-08-16       Impact factor: 3.739

Review 7.  Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Authors:  Lu Miao; Aaron K Holley; Yanming Zhao; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2014-01-22       Impact factor: 8.401

8.  Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.

Authors:  Ilir Agalliu; Erika M Kwon; Claudia A Salinas; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

9.  Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.

Authors:  Xun-long Shi; Zhi-hui Shi; Hai Huang; Hong-guang Zhu; Pei Zhou; Dianwen Ju
Journal:  Inflammation       Date:  2010-06       Impact factor: 4.092

10.  Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.

Authors:  Ting-Yuan David Cheng; Irena B King; Matt J Barnett; Christine B Ambrosone; Mark D Thornquist; Gary E Goodman; Marian L Neuhouser
Journal:  Am J Epidemiol       Date:  2013-03-27       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.